Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Deep Space Energy Secures US$1.1 Million to Advance... February 13, 2026 Beyond the Pilot: Wiring Wall Street’s New Internet February 7, 2026 The True Value of Olympic Gold: Beyond Metal... February 13, 2026 Tech 5: Softbank to Invest US$2 Billion in... August 24, 2025 Boundiali extends strike and depth at BDT3 and... February 16, 2026 Adam Rozencwajg: Gold Stock Gains, Silver and Uranium... June 4, 2025 Binding Option to Acquire 90% of Advanced Pomme... February 13, 2026 BPH Energy LimitedRaises $1.2M to Accelerate Funding of... January 12, 2026 Trump Admin Fast Tracks Anfield’s Velvet-Wood Uranium Project... May 16, 2025 Triumph Gold Announces the Acquisition of the Coyote... June 4, 2025